Kong CY, et al. - In view of the observation that lung cancer is the leading cause of non-AIDS-defining cancer deaths among HIV-infected individuals, researchers examined the benefits and harms of lung cancer screening among these individuals. Analysis of data from Veterans Aging Cohort Study, Kaiser Permanente Northern California HIV Cohort, and medical literature revealed lung cancer screening as helpful in reducing mortality in HIV-infected patients with CD4⁺ cell count at least 500 cells/μl, with a number of efficient strategies for eligibility, including the current Centers for Medicare & Medicaid Services criteria.